Lieff Cabraser Snags $40M Fees From Sandoz, Momenta Deal

Law360 (June 1, 2020, 2:45 PM EDT) -- Lieff Cabraser Heimann & Bernstein LLP and a former firm associate have won $40 million in fees from a $120 million deal they helped hospitals, health insurers and uninsured consumers ink with Sandoz and Momenta over the price of generic blood thinners.

After a hearing on the settlement and fee request Friday afternoon, a Nashville federal judge gave both final approval, doling out a third of the pot in fees, plus a few million in expenses, to Lieff Cabraser and onetime associate John Spragens. Spragens had worked on the case since its inception in 2015 and continued to contribute after he...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!